Tuesday, January 6, 2009 - 8:03PM EST

Clinical Trials

31. Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial.

Author
Albarracin C; Fuqua B; Geohas J; Juturu V; Finch MR; Komorowski JR;
Institution
Alpha Therapy Center, Corpus Christi, TX, USA.
Journal
J Cardiometab Syndr. 2007 Spring;2(2):91-7.
Abstract URL
Click here to view abstract

32. A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet.

Author
Ose L; Johnson-Levonas A; Reyes R; Lin J; Shah A; Tribble D; Musliner T;
Institution
Lipid Clinic, Rikshospitalet, Oslo, Norway. liv.ose@rikshospitalet.no
Journal
Int J Clin Pract. 2007 Sep;61(9):1469-80. Epub 2007 Jul 26.
Abstract URL
Click here to view abstract

33. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.

Author
Sampalis JS; Bissonnette S; Habib R; Boukas S;
Institution
Department of Surgery and Epidemiology, McGill University, Montreal, Quebec, Canada. jsampalis@jssresearch.com
Journal
Ann Pharmacother. 2007 Sep;41(9):1345-51. Epub 2007 Jul 31.
Abstract URL
Click here to view abstract

34. Intake of phenol-rich virgin olive oil improves the postprandial prothrombotic profile in hypercholesterolemic patients.

Author
Ruano J; Lopez-Miranda J; de la Torre R; Delgado-Lista J; Fernandez J; Caballero J; Covas MI; Jimenez Y; Perez-Martinez P; Marin C; Fuentes F; Perez-Jimenez F;
Institution
Lipids and Atherosclerosis Research Unit, Reina Sofia University Hospital, University of Cordoba, Ciber Fisiopatologia Obesidad y Nutricion, Instituto de Salud Carlos III, Spain.
Journal
Am J Clin Nutr. 2007 Aug;86(2):341-6.
Abstract URL
Click here to view abstract

35. Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a population-based study.

Author
Berger AK; Duval SJ; Armstrong C; Jacobs DR Jr; Luepker RV;
Institution
Section of Cardiovascular Medicine, Department of Medicine, and the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN 55454, USA. berger1217@aol.com
Journal
Am J Geriatr Cardiol. 2007 Jan-Feb;16(1):15-23.
Abstract URL
Click here to view abstract

36. Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness trial.

Author
Pearson TA; Denke MA; McBride PE; Battisti WP; Gazzara RA; Brady WE; Palmisano J;
Institution
Department of Community & Preventive Medicine, University of Rochester School of Medicine and Dentistry, NY 14642, USA.
Journal
Mayo Clin Proc. 2006 Sep;81(9):1177-85.
Abstract URL
Click here to view abstract

37. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.

Author
Bays H; Rhyne J; Abby S; Lai YL; Jones M;
Institution
Louisville Metabolic and Atherosclerosis Research Center Inc., Louisville, KY 40213, USA. hbaysmd@aol.com
Journal
Curr Med Res Opin. 2006 Nov;22(11):2191-200.
Abstract URL
Click here to view abstract

38. Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels.

Author
Polagruto JA; Wang-Polagruto JF; Braun MM; Lee L; Kwik-Uribe C; Keen CL;
Institution
Department of Nutrition, University of California, Davis, USA.
Journal
J Am Diet Assoc. 2006 Nov;106(11):1804-13.
Abstract URL
Click here to view abstract

39. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.

Author
Davidson MH; McKenney JM; Shear CL; Revkin JH;
Institution
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA. michaeldavidson@radiantresearch.com
Journal
J Am Coll Cardiol. 2006 Nov 7;48(9):1774-81.
Abstract URL
Click here to view abstract

40. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin.

Author
McKenney JM; Davidson MH; Shear CL; Revkin JH;
Institution
Virginia Commonwealth University, Richmond, Virginia, USA. jmckenney@ncrinc.net
Journal
J Am Coll Cardiol. 2006 Nov 7;48(9):1782-90.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7